MTOR and breast carcinoma: Circulating levels of α-ketoglutarate, which are increased by starvation and mimic calorie restriction via inactivation of mTOR [37], also become significantly elevated in breast cancer patients co-treated with metformin but not in those treated only with a standard combination of chemo- and targeted therapy.